VistaGen Therapeutics, Inc.
VTGN · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $67 | $119 | $17 | $68 |
| Short-Term Investments | $13 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $1 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $0 | $0 |
| Total Curr. Assets | $82 | $121 | $18 | $71 |
| Property Plant & Equip (Net) | $2 | $2 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $1 | $1 |
| Total NC Assets | $2 | $3 | $4 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $84 | $124 | $21 | $75 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $2 | $3 |
| Short-Term Debt | $1 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $3 | $0 | $1 | $1 |
| Other Curr. Liab. | $9 | $3 | $1 | $1 |
| Total Curr. Liab. | $13 | $5 | $5 | $6 |
| LT Debt | $1 | $2 | $2 | $3 |
| Deferred Rev, NC | $0 | $0 | $2 | $2 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $3 | $0 | $0 |
| Total NC Liab. | $1 | $4 | $4 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $3 | $3 |
| Total Liabilities | $14 | $9 | $9 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$408 | -$356 | -$327 | -$268 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $478 | $470 | $339 | $332 |
| Total Equity | $70 | $114 | $12 | $65 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $84 | $124 | $21 | $75 |
| Net Debt | -$66 | -$117 | -$14 | -$65 |